Clinical trials
Completed Phase 3 Lung Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
77 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 4 |
| 2010 | 4 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 7 |
| 2015 | 4 |
| 2016 | 3 |
| 2017 | 5 |
| 2019 | 4 |
| 2020 | 2 |
| 2022 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 77 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 16 |
| National Heart, Lung, and Blood Institute (NHLBI) | 16 |
| Novartis Pharmaceuticals | 7 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 3 |
| Johns Hopkins Bloomberg School of Public Health | 2 |
| Vertex Pharmaceuticals Incorporated | 2 |
| AO GENERIUM | 1 |
| Adrian Hernandez | 1 |
| Bayer | 1 |
| BioNTech SE | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Diseases | 77 |
| Respiratory Tract Diseases | 26 |
| Lung Diseases, Obstructive | 25 |
| Asthma | 20 |
| Bronchial Diseases | 15 |
| Pulmonary Disease, Chronic Obstructive | 14 |
| Respiratory Distress Syndrome | 9 |
| Cystic Fibrosis | 7 |
| Bronchopulmonary Dysplasia | 4 |
| COVID-19 | 4 |
Trials
Showing 1 to 25 of 77. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.